Regulation 2017/745 on medical devices, two major innovations: 1) the physiological action of devices consisting of natural materials such as vegetal matrices; 2) the chemical-physical-mechanical action of devices made of “substances”, which as such are artificial derivatives
The Medical Device Regulation 2017/745 (MDR) enables the development of a wide range of innovative products. With respect to Directive 93/42, the MDR explicitly identifies the so-called “medical devices made of substances” (MDMS) through specific requirements. In addition, the MDR expands the defini...
Saved in:
| Main Author: | Marcella Marletta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-04-01
|
| Series: | Frontiers in Drug Safety and Regulation |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fdsfr.2024.1389406/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Substance-based medical devices made of natural substances: An opportunity for therapeutic innovation
by: Emiliano Giovagnoni, et al.
Published: (2022-09-01) -
Medical Devices Made of Substances: The Need for a Change in Approach in Paediatrics
by: Stefano Stagi
Published: (2022-06-01) -
Role of Establishment of Allowable Limits for Leachable Substances in Safety Evaluation of Medical Devices
by: Fangming XU
Published: (2025-01-01) -
“Made in India”: How’s that for an indigenous medical device?
by: Ganne S. Umamaheswara Rao
Published: (2013-05-01) -
Integrating environmental effects in the benefit-risk assessment of therapeutic products: a proposal and example for sustainable health and healthcare
by: Emiliano Giovagnoni, et al.
Published: (2025-01-01)